CH EPL (R5)
1.0.0-ci-build - ci-build
CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions
CH - EPL Reimbursement SL
- FOPHDossierNumber: FOPH Dossier Number/21203
- status: Reimbursed
- statusDate: 2021-06-01
- listingStatus: Listed
- listingPeriod: 2021-06-01 --> (ongoing)
- firstListingDate: 2021-06-01
- costShare: 10
CH - EPL Product Price
- value: CHF742.20 (CHF)
- type: Ex-factory price
- changeType: Normal price mutation
- changeDate: 2023-12-01
CH - EPL Product Price
- value: CHF823.50 (CHF)
- type: Retail price
- changeType: VAT-change
- changeDate: 2023-12-01
type: Reimbursement SL
Extension | Reference |
, , , , , , | ClinicalUseDefinition: type = indication |
holder: Organization Pfizer AG
Generated Narrative: Organization #holder-Pfizer-AG
Profile: CH EPL Organization
identifier: LOC Identifier/100015286, GLN Identifier/7601001010604
name: Pfizer AG